Initiatives to Prevent Fatal Drug Overdose Mortality After Incarceration

There is a direct relationship between fatal drug overdose and individuals who have been involved with the United States criminal legal system. Fatal drug overdose in the United States has reached unprecedented levels in the last decade, disproportionately affecting individuals involved with the criminal legal system and those who experience intersecting social and structural determinants of health. In addition, evidence shows that the immediate post-release period after incarceration is characterized by elevated overdose mortality. However, current policy structures, including the federal Medicaid Inmate Exclusion Policy, fragmented reentry systems, and inconsistent access to medications for opioid use disorder (MOUD), leave justice-involved populations without essential supports during this high-risk transition. This commentary synthesizes national evidence and proposes 3 policy initiatives to reduce post-incarceration overdose deaths: (1) adoption of the Section 1115 Medicaid Reentry Demonstration Waiver to provide prerelease screening, treatment initiation, care coordination, and bridge medication; (2) implementation of statewide carceral-based recovery support programs that integrate peer recovery coaches, trauma-informed care principles, naloxone training, and warm handoffs to community services; and (3) development of low-threshold community harm reduction hubs offering naloxone distribution, same-day and telehealth-enabled MOUD access, housing navigation, and peer support. These initiatives strengthen care continuity and target the transition periods where risk is greatest. Implementing these evidence-informed strategies is both a public health imperative and a critical step toward advancing health equity for criminal legal system-involved populations.